Clinical Trial: Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Gastric Adenocarcinoma
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Phase II Single-Arm, Window Trial of Tadalafil Effect + Chemotherapy in Patients With Resectable Gastric/GEJ Adenocarcinoma
Brief Summary:
The goal of this clinical trial is to assess the ability of Tadalafil alone and in combination with neoadjuvant FLOT (5-Fluorouracil, Oxaliplatin, and Docetaxel) chemotherapy to suppress myeloid derived suppressor cells (MDSCs) in patients with resectable gastric or gastroesophageal junction adenocarcinoma.Resectable means the tumor may be removed through surgical intervention.Neoadjuvant chemotherapy is chemotherapy received before the primary course of treatment i.e.surgical intervention.The main questions it…
Read more